Claims for Patent: 11,331,325

Summary for Patent: 11,331,325

Title:	Pharmaceutical delivery systems for hydrophobic drugs and compositions comprising same
Abstract:	A drug delivery system for oral administration of hydrophobic drugs with enhanced and extended absorption and improved pharmacokinetics is provided. In one embodiment, formulations comprising testosterone and testosterone esters, e.g., testosterone palmitate, are disclosed. Methods of treating a hormone deficiency or effecting male contraception with the inventive formulations are also provided.
Inventor(s):	Dudley; Robert E. (Murfreesboro, TN), Constantinides; Panayiotis P. (Gurnee, IL)
Assignee:	Clarus Therapeutics, Inc. (Northbrook, IL)
Application Number:	16/656,178
Patent Claims:	1. A method of treating a hypogonadal human male with testosterone deficiency comprising orally administering to a human male in need thereof an oral pharmaceutical composition comprising 15-20 percent by weight of solubilized testosterone undecanoate, 5-20 percent by weight of hydrophilic surfactant, wherein the formulation consists of a liquid or semi-solid encased in a capsule, wherein said administration is twice daily, and wherein the administration provides an average serum concentration of testosterone at steady state of about 300 ng/dl to about 1100 ng/dl. 2. The method as recited in claim 1, wherein said the hydrophilic surfactant exhibits an HLB of 10 to 45. 3. The method of claim 2, in which the hydrophilic surfactant is chosen from polyoxyethylene sorbitan fatty acid esters, hydrogenated castor oil ethoxylates, PEG mono- and di-esters of palmitic and stearic acids, fatty acid ethoxylates, and combinations thereof. 4. The method of claim 3, in which the hydrophilic surfactant is a hydrogenated castor oil ethoxylate. 5. The method of claim 1, wherein the formulation is a liquid encased in a capsule. 6. The method of claim 1, wherein the formulation is a semi-solid encased in a capsule.